Q2 sales rise 21.3%; consolidated H1 loss continues as cash flow turns negative

Revenue Growth 20pctPat NegativeExceptional ItemAuditor Mid Year ChangeRelated Party TransactionsDebt Equity ThresholdResults View source PDF Explain this filing

NACLIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.8%Reaction day

₹217.19

prior close

₹211.99

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%-3.4% vs market

Pesticides & Agrochemicals peers, median of 26sector-0.4%-3.3% vs sector

On the reaction day the stock moved 3.4 pts less than Nifty Microcap 250 and 3.3 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.9

10m

-1.4

15m

-0.9

30m

-1.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.8-0.3-3.4-0.4-3.3

Next day

-8.4+0.1-8.4-0.0-8.3

-5.2+0.3-5.5-0.5-4.6

-6.3+0.8-7.0-0.4-5.9

-6.5+0.6-7.1-0.5-6.0

-6.5+0.2-6.7-1.6-4.9

-7.9+0.5-8.4-3.5-4.4

15d

-11.5-0.1-11.4-8.8-2.7

-16.6-3.5-13.1-10.5-6.2

-22.7-5.0-17.6-9.2-13.5

-29.8-13.4-16.4-17.1-12.7

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved unaudited Q2 and H1 results for September 30, 2025. Consolidated Q2 sales rose 21.3% to Rs 32,623 lakh; net profit was Rs 1,779 lakh versus a Rs 741 lakh loss. Consolidated H1 net loss was Rs 239 lakh and operating cash flow was negative Rs 941 lakh. H1 impairment of Rs 1,745 lakh was exceptional. Shareholders will vote on a material related party deal with Coromandel. New auditor reviewed Q2; prior reviewed June quarter.

Likely market impact

Q2 sales and profit support sentiment, but the H1 loss, negative cash flow, higher borrowings and mid-year auditor change keep risks elevated.